3/27
11:56 am
pfe
Consecutive approvals of Opdivo for Hodgkin's lymphoma to boost sales growth [Yahoo! Finance]
Low
Report
Consecutive approvals of Opdivo for Hodgkin's lymphoma to boost sales growth [Yahoo! Finance]
3/27
03:12 am
pfe
????????????? - ??????????????????2026-2035? [CNET News]
Low
Report
????????????? - ??????????????????2026-2035? [CNET News]
3/26
09:27 pm
pfe
Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data [Yahoo! Finance]
Low
Report
Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data [Yahoo! Finance]
3/26
10:23 am
pfe
Income Investors Face a Hard Truth About Pfizer's Payout Safety [Yahoo! Finance]
Low
Report
Income Investors Face a Hard Truth About Pfizer's Payout Safety [Yahoo! Finance]
3/25
06:24 pm
pfe
Is Pfizer Stock a Buy After This Win? [Yahoo! Finance]
Low
Report
Is Pfizer Stock a Buy After This Win? [Yahoo! Finance]
3/25
04:23 am
pfe
Lyme disease vaccine shows strong results. How it works. [USA TODAY]
Low
Report
Lyme disease vaccine shows strong results. How it works. [USA TODAY]
3/24
10:00 am
pfe
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts
Low
Report
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts
3/24
08:03 am
pfe
Pfizer (PFE) had its price target raised by Guggenheim from $35.00 to $36.00. They now have a "buy" rating on the stock.
Low
Report
Pfizer (PFE) had its price target raised by Guggenheim from $35.00 to $36.00. They now have a "buy" rating on the stock.
3/23
06:59 am
pfe
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial [Yahoo! Finance]
Low
Report
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial [Yahoo! Finance]
3/23
06:45 am
pfe
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
Low
Report
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
3/23
05:46 am
pfe
Have $500? 2 Healthcare Stocks Long-Term Investors Should Buy Right Now [Yahoo! Finance]
Low
Report
Have $500? 2 Healthcare Stocks Long-Term Investors Should Buy Right Now [Yahoo! Finance]
3/20
09:28 pm
pfe
Pfizer Prostate Cancer Data Adds Context To Valuation And Pipeline Outlook [Yahoo! Finance]
Low
Report
Pfizer Prostate Cancer Data Adds Context To Valuation And Pipeline Outlook [Yahoo! Finance]
3/20
04:30 pm
pfe
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
Low
Report
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
3/19
08:10 pm
pfe
Pfizer aims for wider use of PARP drug in prostate cancer with new data [Yahoo! Finance]
Low
Report
Pfizer aims for wider use of PARP drug in prostate cancer with new data [Yahoo! Finance]
3/19
07:31 am
pfe
The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients [Fortune]
Low
Report
The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients [Fortune]
3/19
06:45 am
pfe
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
Low
Report
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
3/18
08:06 pm
pfe
PFE's Atirmociclib 2L Breast Cancer Study Hits Goal, Aid Pipeline Push [Yahoo! Finance]
Low
Report
PFE's Atirmociclib 2L Breast Cancer Study Hits Goal, Aid Pipeline Push [Yahoo! Finance]
3/18
09:50 am
pfe
Contraceptives Drugs Market Size to Reach USD 46.24 Billion by 2035; Rising Awareness of Family Planning Driving Market Growth – SNS Insider [Yahoo! Finance]
Low
Report
Contraceptives Drugs Market Size to Reach USD 46.24 Billion by 2035; Rising Awareness of Family Planning Driving Market Growth – SNS Insider [Yahoo! Finance]
3/18
09:06 am
pfe
Pfizer: I'm Still Expecting A Massive Rebound [Seeking Alpha]
Low
Report
Pfizer: I'm Still Expecting A Massive Rebound [Seeking Alpha]
3/17
06:22 pm
pfe
Jim Cramer Notes Pfizer (PFE) Has “Got a Lot of Stuff in the Pipeline” [Yahoo! Finance]
Low
Report
Jim Cramer Notes Pfizer (PFE) Has “Got a Lot of Stuff in the Pipeline” [Yahoo! Finance]
3/17
04:17 pm
pfe
Pfizer's Ibrance successor moves forward with new study data [Yahoo! Finance]
Low
Report
Pfizer's Ibrance successor moves forward with new study data [Yahoo! Finance]
3/17
03:11 pm
pfe
Pfizer Reports Positive Mid-Stage Breast Cancer Trial Results [Yahoo! Finance]
Low
Report
Pfizer Reports Positive Mid-Stage Breast Cancer Trial Results [Yahoo! Finance]
3/17
01:11 pm
pfe
Pfizer (PFE) was given a new $27.00 price target by Morgan Stanley. They now have a "positive" rating on the stock.
Low
Report
Pfizer (PFE) was given a new $27.00 price target by Morgan Stanley. They now have a "positive" rating on the stock.
3/17
12:30 pm
pfe
Pfizer (PFE) had its price target raised by HSBC Holdings plc from $29.00 to $32.00. They now have a "buy" rating on the stock.
Low
Report
Pfizer (PFE) had its price target raised by HSBC Holdings plc from $29.00 to $32.00. They now have a "buy" rating on the stock.
3/17
11:28 am
pfe
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]
Low
Report
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]